Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 297

1.

"Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia".

Cavallari M, Ciccone M, Falzoni S, Cavazzini F, Formigaro L, Di Virgilio F, Rotola A, Rigolin GM, Cuneo A.

Leuk Res Rep. 2017 Jan 22;7:11-13. doi: 10.1016/j.lrr.2017.01.002.

PMID:
28180067
2.

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.

Parsons E, Otieno JA, Ong'echa JM, Nixon CE, Vulule J, Münz C, Stewart VA, Moormann AM.

PLoS One. 2016 Dec 29;11(12):e0167841. doi: 10.1371/journal.pone.0167841.

PMID:
28033393
3.

Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.

Incrocci R, Barse L, Stone A, Vagvala S, Montesano M, Subramaniam V, Swanson-Mungerson M.

Virology. 2017 Jan;500:96-102. doi: 10.1016/j.virol.2016.10.015.

PMID:
27792904
4.

Viral IL-10 down-regulates the "MHC-I antigen processing operon" through the NF-κB signaling pathway in nasopharyngeal carcinoma cells.

Ren YX, Yang J, Sun RM, Zhang LJ, Zhao LF, Li BZ, Li L, Long HT, Sun QM, Huang YC, Li XJ.

Cytotechnology. 2016 Dec;68(6):2625-2636.

PMID:
27650182
5.

Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade.

Tomita Y, Satomi M, Bracamonte-Baran W, Gan EJ, Workman AS, Workman CJ, Vignali DA, Burlingham WJ.

Transplant Direct. 2016 Apr 21;2(5):e73. doi: 10.1097/TXD.0000000000000580.

PMID:
27500263
6.

Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.

Draborg AH, Sandhu N, Larsen N, Lisander Larsen J, Jacobsen S, Houen G.

J Immunol Res. 2016;2016:6473204. doi: 10.1155/2016/6473204.

PMID:
27110576
7.

Circulating interleukin-10 levels and human papilloma virus and Epstein-Barr virus-associated cancers: evidence from a Mendelian randomization meta-analysis based on 11,170 subjects.

Qu K, Pang Q, Lin T, Zhang L, Gu M, Niu W, Liu C, Zhang M.

Onco Targets Ther. 2016 Mar 7;9:1251-67. doi: 10.2147/OTT.S96772.

PMID:
27022283
8.

Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties.

Quaranta P, Focosi D, Di Iesu M, Cursi C, Zucca A, Curcio M, Lapi S, Boldrini L, Stampacchia G, Paolicchi A, Scatena F, Freer G, Pistello M.

Cytotherapy. 2016 Feb;18(2):205-18. doi: 10.1016/j.jcyt.2015.11.011.

PMID:
26794713
9.

Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.

Park GB, Kim D, Park SJ, Lee HK, Kim JH, Kim YS, Park SG, Choi IH, Yoon SH, Lee YJ, Paeng S, Hur DY.

Int J Mol Med. 2015 Dec;36(6):1464-78. doi: 10.3892/ijmm.2015.2372.

PMID:
26498453
10.

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.

Wang H, Wang L, Wuxiao Z, Huang H, Jiang W, Li Z, Lu Y, Xia Z.

Onco Targets Ther. 2015 Sep 14;8:2589-99. doi: 10.2147/OTT.S91077.

PMID:
26396532
11.

Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.

Sousa H, Mesquita L, Ribeiro J, Catarino R, Breda E, Medeiros R.

Immunobiology. 2016 Feb;221(2):145-52. doi: 10.1016/j.imbio.2015.09.015.

PMID:
26391153
12.
13.

MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV.

Wang L, Li G, Yao ZQ, Moorman JP, Ning S.

Rev Med Virol. 2015 Sep;25(5):320-41. doi: 10.1002/rmv.1850. Review.

PMID:
26258805
14.

Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Cárdenas D, Vélez G, Orfao A, Herrera MV, Solano J, Olaya M, Uribe AM, Saavedra C, Duarte M, Rodríguez M, López M, Fiorentino S, Quijano S.

Clin Exp Immunol. 2015 Nov;182(2):173-83. doi: 10.1111/cei.12682.

PMID:
26174440
15.

Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival.

Harris-Arnold A, Arnold CP, Schaffert S, Hatton O, Krams SM, Esquivel CO, Martinez OM.

Am J Transplant. 2015 Nov;15(11):2814-24. doi: 10.1111/ajt.13375.

PMID:
26147452
16.

Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.

Pimienta G, Fok V, Haslip M, Nagy M, Takyar S, Steitz JA.

PLoS One. 2015 Jun 29;10(6):e0124638. doi: 10.1371/journal.pone.0124638.

PMID:
26121143
17.

Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation.

Panikkar A, Smith C, Hislop A, Tellam N, Dasari V, Hogquist KA, Wykes M, Moss DJ, Rickinson A, Balfour HH Jr, Khanna R.

J Infect Dis. 2015 Dec 15;212(12):1957-61. doi: 10.1093/infdis/jiv340.

PMID:
26080368
18.

Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.

Savitri E, Haryana MS.

Glob J Health Sci. 2015 Apr 23;7(3):364-72. doi: 10.5539/gjhs.v7n3p364.

PMID:
25948470
19.

Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice.

Rahal EA, Hajjar H, Rajeh M, Yamout B, Abdelnoor AM.

Viral Immunol. 2015 Jun;28(5):297-302. doi: 10.1089/vim.2014.0129.

PMID:
25870901
20.

Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation.

Lindquester GJ, Greer KA, Stewart JP, Sample JT.

Herpesviridae. 2014 Sep 24;5:1. doi: 10.1186/2042-4280-5-1.

PMID:
25324959
Items per page

Supplemental Content

Loading ...
Support Center